Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker (Exosomes, CTC), By Technology, By Sample Type, By Application, By Clinical Application, By End-use, By Product, By Region, And Segment Forecasts, 2023 - 2030

Report
150 Pages
May 2023
Region: Global
Grand View Research
ID: 4582091

Quick Summary:

As industries continue to develop at a rapid pace, reliable, actionable data drives the informed decision-making that elevates business success. Informed professionals require in-depth, curated market research that empowers strategic decisions. For those positioned in the healthcare sector, comprehensive understanding of the global liquid biopsy market is invaluable.

Escalating rates of cancer combined with increasing global population demographic shifts are the primary drivers of the market. Moreover, the medical industry's increasingly keen focus on early disease detection underlined by trendsetting technological advancements are forging a dynamic marketplace. With an emphasis on noninvasive treatment protocols, the liquid biopsy space presents significant future growth opportunities.

The soaring interest in liquid biopsy technologies, rising approval of new product offerings, positive study outcomes and policy support outline a future ripe with potential. This report illuminates these underlying drivers, exploring factors that businesses must understand to effectively tap into the unfolding future landscape of the liquid biopsy market.

The global liquid biopsy market size is expected to reach USD 22.86 billion by 2030, expanding at a CAGR of 12.46% from 2023 to 2030. The increasing prevalence of cancer and the growing geriatric population are major drivers expected to fuel market growth. Furthermore, the use of technologically advanced devices for early detection of diseases is one of the key factors driving the market. In addition, the increasing preference for noninvasive treatment procedures will offer lucrative opportunities in the forecast period.

In recent years, cases of cancer have been rising tremendously and the trend is projected to remain the same in the foreseeable future. A significant shift in lifestyle has exposed the global population to this disorder and has resulted in oncogenic factors. For instance, as per the American Cancer Society, in 2022, the number of new cancer cases is expected to reach 1.9 million, leading to 609,360 deaths. Companies are focusing on expanding their business operations in the clinical liquid biopsy space.

For instance, in December 2021, Helio Health and Fulgent Genetics announced the launch of the former’s HelioLiver, a new liquid biopsy test for early liver cancer detection. This liquid biopsy test combines serum protein markers and cell-free DNA methylation patterns. Additionally, new research studies are aiding the development of novel liquid biopsy techniques. For instance, in July 2022, the University of Central Florida announced the development of a novel liquid biopsy technique that facilitates early detection using biomarker identification for lung and breast cancer, making the monitoring of conditions easier.

The enhanced interest of players in liquid biopsy and the increasing rate of approval of new products are further accelerating market growth. Moreover, in the past several years, studies have shown a positive outcome of liquid biopsy platforms. Governments and various regulatory bodies have also shown interest in the area by promoting multiple breakthrough devices for the rapid development of this technology. With the high adoption of the technology by various companies, along with the support of government funding and initiatives, the market is expected to grow in the coming years.

Liquid Biopsy Market Report Highlights

The ctDNA segment is projected to hold the largest share in the market owing to its wide use as a biomarker in the detection of cancer using liquid biopsy
The multi-gene-parallel analysis (NGS) technology segment is expected to grow lucratively due to increasing research and development, increasing cancer cases, advancements in technology, and strategic activities by leading companies
North America dominated the global market in 2022, owing to the increasing demand for new technologies, a large pool of key players, the presence of several clinical laboratories, and advanced healthcare infrastructure in the region
Asia Pacific is expected to grow considerably in the future, owing to the rising prevalence of target conditions in the region and the presence of key players

This product will be delivered within 1-3 business days.

Frequently Asked Questions about the Global Liquid Biopsy Market

What is the estimated value of the Global Liquid Biopsy Market?

The Global Liquid Biopsy Market was estimated to be valued at $8.94 Billion in 2022.

What is the growth rate of the Global Liquid Biopsy Market?

The growth rate of the Global Liquid Biopsy Market is 12.4%, with an estimated value of $22.86 Billion by 2030.

What is the forecasted size of the Global Liquid Biopsy Market?

The Global Liquid Biopsy Market is estimated to be worth $22.86 Billion by 2030.

Who are the key companies in the Global Liquid Biopsy Market?

Key companies in the Global Liquid Biopsy Market include ONCIMMUNE, THERMO FISHER SCIENTIFIC, INC, MYRIAD GENETICS, INC, F. HOFFMANN, LA ROCHE LTD, ILLUMINA, INC, QIAGEN, BIOCEPT, INC, GUARDANT HEALTH and LUCENCE HEALTH INC.

Report Attribute	Details
No. of Pages	150
Published	May 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 8.94 Billion
Forecasted Market Value ( USD ) by 2030	$ 22.86 Billion
Compound Annual Growth Rate	12.4%
Regions Covered	Global
No. of Companies Mentioned	12

Chapter 1 Liquid Biopsy Market: Methodology And Scope

1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective 1:
1.4.2 Objective 2:
1.4.2 Objective 2:
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations

Chapter 2 Liquid Biopsy Market: Executive Summary

2.1 Liquid Biopsy Market: Market Outlook
2.1.1 Market Summary

Chapter 3 Liquid Biopsy Market: Industry Outlook

3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Increasing prevalence of cancer
3.3.1.2 Growing geriatric population
3.3.1.3 Technological advancement
3.3.1.3 Increasing preference for noninvasive treatment
3.3.2 Market Restraint Analysis
3.3.2.1 Patent expiry of blockbuster drugs prescribed
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter’s Five Forces
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 New Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnerships
3.7.5 Marketing & Promotions

Chapter 4 Liquid Biopsy Market: Competitive Landscape

4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Ansoff Matrix
4.2 Company Categorization
4.2.1 Innovators
4.2.1.1 Market Differentiators
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market Share Analysis, 2022
4.4 Public Companies
4.4.1 Competitive Dashboard Analysis
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.6 Regional Network Map

Chapter 5 Liquid Biopsy Market: Sample Type Business Analysis

5.1 Liquid Biopsy Market: Sample Type Movement Analysis
5.2 Blood Sample
5.2.1 Blood Sample Market Estimates And Forecast, 2018 - 2030 (Usd Million)
5.3 Others
5.3.1 Others Market Estimates And Forecast, 2018 - 2030 (Usd Million)

Chapter 6 Liquid Biopsy Market: Biomarker Business Analysis

6.1 Liquid Biopsy Market: Biomarker Movement Analysis
6.2 Circulating Tumor Cells (CTCs)
6.2.1 Circulating Tumor Cells (Ctcs) Estimates And Forecast, 2018 - 2030 (Usd Million)
6.3 Circulating Tumor Dna (Ctdna)
6.3.1 Urine Sample Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.4 Extracellular Vesicles (Evs)
6.4.1 Extracellular Vesicles (Ev) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.5 Others
6.5.1 Others Market Estimates And Forecast, 2018 - 2030 (Usd Million)

Chapter 7 Liquid Biopsy Market: Technology Business Analysis

7.1 Liquid Biopsy Market: Technology Movement Analysis
7.2 Multi-gene-parallel Analysis (NGS)
7.2.1 Multi-Gene-Parallel Analysis (Ngs) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
7.3 Single Gene Analysis (Pcr Microarrays)
7.3.1 Single Gene Analysis (Pcr Microassays) Market Estimates And Forecast, 2018 - 2030 (Usd Million)

Chapter 8 Liquid Biopsy Market: Application Business Analysis

8.1 Liquid Biopsy Market: Application Movement Analysis
8.2 Cancer
8.2.1 Cancer Market Estimates And Forecast, 2018 - 2030 (Usd Million)
8.3 Reproductive Health
8.3.1 Reproductive Health Market Estimates And Forecast, 2018 - 2030 (Usd Million)
8.4 Others
8.4.1 Others Market Estimates And Forecast, 2018 - 2030 (Usd Million)

Chapter 9 Liquid Biopsy Market: End-use Business Analysis

9.1 Liquid Biopsy Market: End-use Movement Analysis
9.2 Hospitals and Laboratories
9.2.1 Hospitals And Laboratories Market Estimates And Forecast, 2018 - 2030 (Usd Million)
9.3 Speciality Clinics
9.3.1 Speciality Clinics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
9.4 Academic And Research Centers
9.4.1 Academic And Research Centers Market Estimates And Forecast, 2018 - 2030 (Usd Million)
9.5 Others
9.5.1 Others Market Estimates And Forecast, 2018 - 2030 (Usd Million)

Chapter 10 Liquid Biopsy Market: Clinical Application Business Analysis

10.1 Liquid Biopsy Market: Clinical Application Movement Analysis
10.2 Therapy Selection
10.2.1 Therapy Selection Market Estimates And Forecast, 2018 - 2030 (Usd Million)
10.3 Treatment Monitoring
10.3.1 Treatment Monitoring Market Estimates And Forecast, 2018 - 2030 (Usd Million)
10.4 Early Cancer Screening
10.4.1 Early Cancer Screening Market Estimates And Forecast, 2018 - 2030 (Usd Million)
10.5 Recurrence Monitoring
10.5.1 Recurrence Monitoring Market Estimates And Forecast, 2018 - 2030 (Usd Million)
10.6 Others
10.6.1 Others Market Estimates And Forecast, 2018 - 2030 (Usd Million)

Chapter 11 Liquid Biopsy Market: Product Business Analysis

11.1 Liquid Biopsy Market: Product Movement Analysis
11.2 Instruments
11.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (Usd Million)
11.3 Consumables Kits And Reagents
11.3.1 Consumables Kits And Reagents Market Estimates And Forecast, 2018 - 2030 (Usd Million)
11.4 Software And Services
11.4.1 Software And Services Market Estimates And Forecast, 2018 - 2030 (Usd Million)

Chapter 12 Liquid Biopsy Market: Regional Business Analysis

12.1 Definition & Scope
12.2 Regional Market Share Analysis, 2021 & 2030
12.3 Regional Market Dashboard
12.4 Regional Market Snapshot
12.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
12.5.1 North America
12.5.2 Europe
12.5.3 Asia Pacific
12.5.4 Latin America
12.5.5 MEA
12.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
12.7 North America
12.7.1 North America Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.7.2 U.S.
12.7.2.1 U.S. Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.7.2.2 Key country Dynamics
12.7.2.3 Regulatory Framework
12.7.2.4 Competitive Scenario
12.7.2.5 Recent Developments
12.7.2.6 Investments Scenario
12.7.3 Canada
12.7.3.1 Canada Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.7.3.2 Key country Dynamics
12.7.3.3 Regulatory Framework
12.7.3.4 Competitive Scenario
12.7.3.5 Recent Developments
12.7.3.6 Investments Scenario
12.8 Europe
12.8.1 Europe Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.8.2 UK
12.8.2.1 UK Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.8.2.2 Key country Dynamics
12.8.2.3 Regulatory Framework
12.8.2.4 Competitive Scenario
12.8.2.5 Recent Developments
12.8.2.6 Investments Scenario
12.8.3 Germany
12.8.3.1 Germany Liquid Biopsy Market, 2018 - 2030 (Usd Million)
12.8.3.2 Key Country Dynamics
12.8.3.3 Regulatory Framework
12.8.3.4 Competitive Scenario
12.8.3.5 Recent Developments
12.8.3.6 Investments Scenario
12.8.4 Spain
12.8.4.1 Spain Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.8.4.2 Key country Dynamics
12.8.4.3 Regulatory Framework
12.8.4.4 Competitive Scenario
12.8.4.5 Recent Developments
12.8.4.6 Investments Scenario
12.8.5 France
12.8.5.1 France Liquid Biopsy Market, 2018 - 2030 (Usd Million)
12.8.5.2 Key Country Dynamics
12.8.5.3 Regulatory Framework
12.8.5.4 Competitive Scenario
12.8.5.5 Recent Developments
12.8.5.6 Investments Scenario
12.8.6 Italy
12.8.6.1 Italy Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.8.6.2 Key country Dynamics
12.8.6.3 Regulatory Framework
12.8.6.4 Competitive Scenario
12.8.6.5 Recent Developments
12.8.6.6 Investments Scenario
12.8.7 Denmark
12.8.7.1 Denmark Liquid Biopsy Market, 2018 - 2030 (Usd Million)
12.8.7.2 Key Country Dynamics
12.8.7.3 Regulatory Framework
12.8.7.4 Competitive Scenario
12.8.7.5 Recent Developments
12.8.7.6 Investments Scenario
12.8.8 Sweden
12.8.8.1 Sweden Liquid Biopsy Market, 2018 - 2030 (Usd Million)
12.8.8.2 Key Country Dynamics
12.8.8.3 Regulatory Framework
12.8.8.4 Competitive Scenario
12.8.8.5 Recent Developments
12.8.8.6 Investments Scenario
12.8.9 Norway
12.8.9.1 Norway Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.8.9.2 Key country Dynamics
12.8.9.3 Regulatory Framework
12.8.9.4 Competitive Scenario
12.8.9.5 Recent Developments
12.8.9.6 Investments Scenario
12.9 Asia Pacific
12.9.1 Asia-Pacific Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.9.2 Japan
12.9.2.1 Japan Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.9.2.2 Key country Dynamics
12.9.2.3 Regulatory Framework
12.9.2.4 Competitive Scenario
12.9.2.5 Recent Developments
12.9.2.6 Investments Scenario
12.9.3 China
12.9.3.1 China Liquid Biopsy Market, 2018 - 2030 (Usd Million)
12.9.3.2 Key Country Dynamics
12.9.3.3 Regulatory Framework
12.9.3.4 Competitive Scenario
12.9.3.5 Recent Developments
12.9.3.6 Investments Scenario
12.9.4 India
12.9.4.1 India Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.9.4.2 Key country Dynamics
12.9.4.3 Regulatory Framework
12.9.4.4 Competitive Scenario
12.9.4.5 Recent Developments
12.9.4.6 Investments Scenario
12.9.5 South Korea
12.9.5.1 South Korea Liquid Biopsy Market, 2018 - 2030 (Usd Million)
12.9.5.2 Key Country Dynamics
12.9.5.3 Regulatory Framework
12.9.5.4 Competitive Scenario
12.9.5.5 Recent Developments
12.9.5.6 Investments Scenario
12.9.6 Thailand
12.9.6.1 Thailand Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.9.6.2 Key country Dynamics
12.9.6.3 Regulatory Framework
12.9.6.4 Competitive Scenario
12.9.6.5 Recent Developments
12.9.6.6 Investments Scenario
12.9.7 Australia
12.9.7.1 Australia Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.9.7.2 Key country Dynamics
12.9.7.3 Regulatory Framework
12.9.7.4 Competitive Scenario
12.9.7.5 Recent Developments
12.9.7.6 Investments Scenario
12.10 Latin America
12.10.1 Latin America Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.10.2 Brazil
12.10.2.1 Brazil Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.10.2.2 Key country Dynamics
12.10.2.3 Regulatory Framework
12.10.2.4 Competitive Scenario
12.10.2.5 Recent Developments
12.10.2.6 Investments Scenario
12.10.3 MEXICO
12.10.3.1 Mexico Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.10.3.2 Key country Dynamics
12.10.3.3 Regulatory Framework
12.10.3.4 Competitive Scenario
12.10.3.5 Recent Developments
12.10.3.6 Investments Scenario
12.10.4 ARGENTINA
12.10.4.1 Argentina Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.10.4.2 Key country Dynamics
12.10.4.3 Regulatory Framework
12.10.4.4 Competitive Scenario
12.10.4.5 Recent Developments
12.10.4.6 Investments Scenario
12.11 MEA
12.11.1 MEA Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.11.2 South Africa
12.11.2.1 South Africa Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.11.2.2 Key country Dynamics
12.11.2.3 Regulatory Framework
12.11.2.4 Competitive Scenario
12.11.2.5 Recent Developments
12.11.2.6 Investments Scenario
12.11.3 Saudi Arabia
12.11.3.1 Saudi Arabia Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.11.3.2 Key country Dynamics
12.11.3.3 Regulatory Framework
12.11.3.4 Competitive Scenario
12.11.3.5 Recent Developments
12.11.3.6 Investments Scenario
12.11.4 UAE
12.11.4.1 UAE Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.11.4.2 Key country Dynamics
12.11.4.3 Regulatory Framework
12.11.4.4 Competitive Scenario
12.11.4.5 Recent Developments
12.11.4.6 Investments Scenario
12.11.5 Kuwait
12.11.5.1 Kuwait Liquid Biopsy Market, 2018 - 2030 (USD Million)
12.11.5.2 Key country Dynamics
12.11.5.3 Regulatory Framework
12.11.5.4 Competitive Scenario
12.11.5.5 Recent Developments
12.11.5.6 Investments Scenario

Chapter 13 Liquid Biopsy Market: Company Profiling

13.1 Company Profiles
13.1.1 ONCIMMUNE
13.1.1.1 Company overview
13.1.1.2 Financial performance
13.1.1.3 Product benchmarking
13.1.1.4 Strategic initiatives
13.1.2 THERMO FISHER SCIENTIFIC, INC
13.1.2.1 Company overview
13.1.2.2 Financial performance
13.1.2.3 Product benchmarking
13.1.2.4 Strategic initiatives
13.1.3 MYRIAD GENETICS, INC
13.1.3.1 Company overview
13.1.3.2 Financial performance
13.1.3.3 Product benchmarking
13.1.3.4 Strategic initiatives
13.1.4 F. HOFFMANN-LA ROCHE LTD
13.1.4.1 Company overview
13.1.4.2 Financial performance
13.1.4.3 Product benchmarking
13.1.4.4 Strategic initiatives
13.1.5 ILLUMINA, INC
13.1.5.1 Company overview
13.1.5.2 Financial performance
13.1.5.3 Product benchmarking
13.1.5.4 Strategic initiatives
13.1.6 QIAGEN
13.1.6.1 Company overview
13.1.6.2 Financial performance
13.1.6.3 Product benchmarking
13.1.6.4 Strategic initiatives
13.1.7 BIOCEPT, INC
13.1.7.1 Company overview
13.1.7.2 Financial performance
13.1.7.3 Product benchmarking
13.1.7.4 Strategic initiatives
13.1.8 GUARDANT HEALTH
13.1.8.1 Company overview
13.1.8.2 Financial performance
13.1.8.3 Product benchmarking
13.1.8.4 Strategic initiatives
13.1.9 LUCENCE HEALTH INC
13.1.9.1 Company overview
13.1.9.2 Financial performance
13.1.9.3 Product benchmarking
13.1.9.4 Strategic initiatives
13.1.10 FREENOME HOLDINGS, INC.
13.1.10.1 Company overview
13.1.10.2 Financial performance
13.1.10.3 Product benchmarking
13.1.10.4 Strategic initiatives
13.1.11 ANGLE PLC
13.1.11.1 Company overview
13.1.11.2 Financial performance
13.1.11.3 Product benchmarking
13.1.11.4 Strategic initiatives
13.1.12 EPIGENOMICS AG.
13.1.12.1 Company overview
13.1.12.2 Financial performance
13.1.12.3 Product benchmarking
13.1.12.4 Strategic initiatives

List of Tables

Table 1
Table 2 Global Liquid Biopsy Market, By Region, 2018 - 2030 (USD Million)
Table 3 Global Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 4 Global Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 5 Global Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 6 Global Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 7 Global Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 8 Global Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 9 Global Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 10 North America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
Table 11 North America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 12 North America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 13 North America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 14 North America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 15 North America Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 16 North America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 17 North America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 18 U.S. Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 19 U.S. Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 20 U.S. Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 21 U.S. Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 22 U.S. Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 23 U.S. Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 24 U.S. Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 25 Canada Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 26 Canada Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 27 Canada Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 28 Canada Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 29 Canada Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 30 Canada Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 31 Canada Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 32 Europe Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
Table 33 Europe Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 34 Europe Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 35 Europe Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 36 Europe Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 37 Europe Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 38 Europe Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 39 Europe Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 40 UK Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 41 UK Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 42 UK Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 43 UK Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 44 UK Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 45 UK Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 46 UK Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 47 Germany Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 48 Germany Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 49 Germany Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 50 Germany Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 51 Germany Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 52 Germany Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 53 Germany Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 54 France Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 55 France Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 56 France Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 57 France Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 58 France Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 59 France Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 60 France Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 61 Italy Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 62 Italy Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 63 Italy Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 64 Italy Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 65 Italy Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 66 Italy Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 67 Italy Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 68 Spain Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 69 Spain Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 70 Spain Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 71 Spain Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 72 Spain Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 73 Spain Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 74 Spain Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 75 Denmark Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 76 Denmark Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 77 Denmark Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 78 Denmark Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 79 Denmark Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 80 Denmark Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 81 Denmark Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 82 Sweden Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 83 Sweden Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 84 Sweden Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 85 Sweden Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 86 Sweden Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 87 Sweden Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 88 Sweden Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 89 Norway Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 90 Norway Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 91 Norway Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 92 Norway Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 93 Norway Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 94 Norway Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 95 Norway Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 96 Asia Pacific Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
Table 97 Asia Pacific Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 98 Asia Pacific Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 99 Asia Pacific Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 100 Asia Pacific Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 101 Asia Pacific Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 102 Asia Pacific Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 103 Asia Pacific Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 104 Japan Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 105 Japan Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 106 Japan Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 107 Japan Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 108 Japan Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 109 Japan Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 110 Japan Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 111 China Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 112 China Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 113 China Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 114 China Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 115 China Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 116 China Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 117 China Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 118 India Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 119 India Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 120 India Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 121 India Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 122 India Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 123 India Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 124 India Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 125 Australia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 126 Australia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 127 Australia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 128 Australia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 129 Australia Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 130 Australia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 131 Australia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 132 South Korea Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 133 South Korea Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 134 South Korea Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 135 South Korea Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 136 South Korea Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 137 South Korea Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 138 South Korea Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 139 Thailand Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 140 Thailand Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 141 Thailand Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 142 Thailand Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 143 Thailand Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 144 Thailand Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 145 Thailand Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 146 Latin America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
Table 147 Latin America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 148 Latin America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 149 Latin America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 150 Latin America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 151 Latin America Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 152 Latin America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 153 Latin America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 154 Brazil Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 155 Brazil Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 156 Brazil Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 157 Brazil Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 158 Brazil Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 159 Brazil Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 160 Brazil Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 161 Mexico Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 162 Mexico Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 163 Mexico Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 164 Mexico Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 165 Mexico Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 166 Mexico Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 167 Mexico Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 168 Argentina Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 169 Argentina Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 170 Argentina Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 171 Argentina Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 172 Argentina Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 173 Argentina Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 174 Argentina Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 175 Middle East & Africa Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
Table 176 Middle East & Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 177 Middle East & Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 178 Middle East & Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 179 Middle East & Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 180 Middle East & Africa Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 181 Middle East & Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 182 Middle East & Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 183 South Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 184 South Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 185 South Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 186 South Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 187 South Africa Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 188 South Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 189 South Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 190 Saudi Arabia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 191 Saudi Arabia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 192 Saudi Arabia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 193 Saudi Arabia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 194 Saudi Arabia Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 195 Saudi Arabia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 196 Saudi Arabia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 197 UAE Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 198 UAE Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 199 UAE Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 200 UAE Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 201 UAE Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 202 UAE Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 203 UAE Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 204 Kuwait Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 205 Kuwait Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 206 Kuwait Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 207 Kuwait Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 208 Kuwait Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 209 Kuwait Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 210 Kuwait Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Liquid biopsy market segmentation
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restraint relevance analysis (Current & future impact)
Fig. 10 Market challenge relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Market penetration vs growth prospect mapping
Fig. 15 Liquid biopsy market: Sample Type movement analysis
Fig. 16 Blood sample liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 17 Others liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 18 Liquid biopsy market: Biomarker movement analysis
Fig. 19 Circulating Tumor Cells (CTCs) liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 20 Circulating Tumor DNA (ctDNA) liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 21 Extracellular Vesicles (EVs) liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 22 Others liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 23 Liquid biopsy market: Technology movement analysis
Fig. 24 Multi-gene-parallel analysis (NGS) liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 25 Single gene analysis (PCR Microarrays) liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 26 Liquid biopsy market: Application movement analysis
Fig. 27 Cancer liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 28 Lung cancer liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 29 Prostate cancer liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 30 Breast cancer liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 31 Colorectal cancer liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 32 Leukemia liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 33 Gastrointestinal cancer liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 34 Others liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 35 Reproductive Health liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 36 Others liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 37 Liquid biopsy market: End-use movement analysis
Fig. 38 Hospitals and Laboratories liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 39 Specialty clinics liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 40 Academic and research centers liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 41 Others liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 42 Liquid biopsy market: Clinical application movement analysis
Fig. 43 Therapy selection liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 44 Treatment monitoring liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 45 Early cancer screening liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 46 Recurrence monitoring liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 47 Others liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 48 Liquid biopsy market: Product movement analysis
Fig. 49 Instruments liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 50 Consumables kits and reagents liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 51 Software and Services liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 52 Regional marketplace: Key takeaways
Fig. 53 Regional outlook, 2018 & 2030
Fig. 54 North America liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 55 U.S. liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 56 Canada liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 57 Europe liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 58 UK liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 59 Germany liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 60 Italy liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 61 Spain liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 62 France liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 63 Denmark liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 64 Sweden liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 65 Norway liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 66 Asia Pacific liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 67 Japan liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 68 China liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 69 India liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 70 Australia liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 71 South Korea liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 72 Thailand liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 73 Latin America liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 74 Brazil liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 75 Mexico liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 76 Argentina liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 77 MEA liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 78 South Africa liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 79 Saudi Arabia liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 80 UAE liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 81 Kuwait liquid biopsy market, 2018 - 2030 (USD Million)

Companies Mentioned

ONCIMMUNE
THERMO FISHER SCIENTIFIC, INC
MYRIAD GENETICS, INC
F. HOFFMANN-LA ROCHE LTD
ILLUMINA, INC
QIAGEN
BIOCEPT, INC
GUARDANT HEALTH
LUCENCE HEALTH INC
FREENOME HOLDINGS, INC.
ANGLE PLC
EPIGENOMICS AG.

Methodology

LOADING...

PURCHASE OPTIONS

Single User License PDF

1 - 5 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5716EUR$5,950USD£4,908GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6677EUR$6,950USD£5,733GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8598EUR$8,950USD£7,382GBP

Quick Summary:

Liquid Biopsy Market Report Highlights

What is the estimated value of the Global Liquid Biopsy Market?

What is the growth rate of the Global Liquid Biopsy Market?

What is the forecasted size of the Global Liquid Biopsy Market?

Who are the key companies in the Global Liquid Biopsy Market?

Table of Contents

Companies Mentioned

Methodology

Related Topics

Related Reports

Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027

Biomarkers Market by Product & Service (Consumable, Service, Software), Type (Safety, Efficacy, Validation), Disease (Cancer, Infectious, Neurological), Application (Diagnostics, Drug Discovery, Personalized Medicine), Region - Global Forecast to 2028

Global Liquid Biopsy Market by Biomarkers (Cell-free DNA, Circulating Tumor Cells, Circulating Tumor DNA), Sample (Blood Based, Urine Based), Type, Technology, Indication, End-User, Application - Forecast 2023-2030

Global Breast Cancer Liquid Biopsy Market by Biomarker (Cell-free DNA, Circulating Tumor Cells, Extracellular Vesicles), End-User (Hospitals & Physician Laboratories, Reference Laboratories) - Forecast 2023-2030

Global Liquid Biopsy Market - Analysis by Biomarker Type (CTCs, ctDNA, EVs, Others), Product (Assay Kits, Instruments and Devices, Services), By Indication By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)